Clinical trials: VHL Syndrome, open to volunteers
VHL - Von Hippel-Lindau Syndrome
Belzutifan VHL RCC HK Prospective Registry
This study aims to evaluate the Belzutifan's efficacy, drug safety, disease course, and the health-economic impact of the treatment to Von Hippel-Lindau (VHL) syndrome.
- Trial name
- NCT07554508
- Where
- Hong Kong
- Volunteers
- 100 people
- Sponsor
- Chinese University of Hong Kong
VHL - Von Hippel-Lindau Syndrome
CAT-VHL Exploring the Role of Carbonic Anhydrase IX as Diagnostic and Theranostic Target in Von-Hippel Lindau Disease
The study is a phase 2, non-comparative and non-randomized, single arm, national clinical trial testing the hypothesis that CAIX-PET has diagnostic and theranostic potential in VHL disease and in VHL-/- tumors.
- Trial name
- CAT-VHL (NCT07171905)
- Testing
- investigating the role of CAIX as target in VHL disease and in VHL-/- tumors.
- Where
- Italy
- Volunteers
- 38 people
- Sponsor
- IRCCS Ospedale San Raffaele